Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Laura Caberlotto
Affiliation
The Microsoft Research University of Trento
ORCID
Career Start Year
1997
Papers
49
H Index
25
Expertise
CM4AI Collaborator
Timothy Clark (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37174725
Protein Networks Associated with Native Metabotropic Glutamate 1 Receptors (mGlu<sub>1</sub>) in the Mouse Cerebellum.
Cells
2023
33546175
Degree Adjusted Large-Scale Network Analysis Reveals Novel Putative Metabolic Disease Genes.
Biology (Basel)
2021
33197196
Selective Inhibitors of G2019S-LRRK2 Kinase Activity.
J Med Chem
2020
31813757
Gene expression signature of antidepressant treatment response/non-response in Flinders Sensitive Line rats subjected to maternal separation.
Eur Neuropsychopharmacol
2020
30850634
Cross-disease analysis of Alzheimer's disease and type-2 Diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseases.
Sci Rep
2019
29529088
Combined use of protein biomarkers and network analysis unveils deregulated regulatory circuits in Duchenne muscular dystrophy.
PLoS One
2018
29950584
Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depression.
Neuropsychopharmacology
2018
27713095
Nutrition for the ageing brain: Towards evidence for an optimal diet.
Ageing Res Rev
2017
27079753
Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease.
Alzheimers Dement
2016
27612656
Systems biology integration of proteomic data in rodent models of depression reveals involvement of the immune response and glutamatergic signaling.
Proteomics Clin Appl
2016
27585646
Integration of transcriptomic and genomic data suggests candidate mechanisms for APOE4-mediated pathogenic action in Alzheimer's disease.
Sci Rep
2016
26799652
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Autophagy
2016
25362968
Systems biology meets -omic technologies: novel approaches to biomarker discovery and companion diagnostic development.
Expert Rev Mol Diagn
2015
26608884
Systems biology approaches to study the molecular effects of caloric restriction and polyphenols on aging processes.
Genes Nutr
2015
26154857
Novel drug target identification for the treatment of dementia using multi-relational association mining.
Sci Rep
2015
24551850
Network analysis of neurodegenerative disease highlights a role of Toll-like receptor signaling.
Biomed Res Int
2014
24908109
A systems biology investigation of neurodegenerative dementia reveals a pivotal role of autophagy.
BMC Syst Biol
2014
23793101
Differential effects of glycogen synthase kinase 3 (GSK3) inhibition by lithium or selective inhibitors in the central nervous system.
Naunyn Schmiedebergs Arch Pharmacol
2013
24265728
The central role of AMP-kinase and energy homeostasis impairment in Alzheimer's disease: a multifactor network analysis.
PLoS One
2013
20868698
Central administration of NPY or an NPY-Y5 selective agonist increase in vivo extracellular monoamine levels in mesocorticolimbic projecting areas.
Neuropharmacology
2011
21055451
Neuropeptide Y-Y2 receptor knockout mice: influence of genetic background on anxiety-related behaviors.
Neuroscience
2011
19846047
Chronic psychosocial stress alters NPY system: different effects in rat and tree shrew.
Prog Neuropsychopharmacol Biol Psychiatry
2010
21074426
The identification of a series of novel, soluble non-peptidic neuropeptide Y Y2 receptor antagonists.
Bioorg Med Chem Lett
2010
20813523
Discovery and structure-activity relationship of a novel spirocarbamate series of NPY Y5 antagonists.
Bioorg Med Chem Lett
2010
20832426
Adenoviral-mediated Cre expression effectively suppresses GlyT1 binding in the thalamic area of GlyT1 conditional knock-out mice.
J Neurosci Methods
2010
20951033
Design, synthesis and SAR of a novel series of benzimidazoles as potent NPY Y5 antagonists.
Bioorg Med Chem Lett
2010
20630754
Synthesis and structure-activity relationship of N-(3-azabicyclo[3.1.0]hex-6-ylmethyl)-5-(2-pyridinyl)-1,3-thiazol-2-amines derivatives as NPY Y5 antagonists.
Bioorg Med Chem Lett
2010
19607714
Evaluation of expression and function of the H+/myo-inositol transporter HMIT.
BMC Cell Biol
2009
19581086
The identification and optimisation of novel and selective diamide neuropeptide Y Y2 receptor antagonists.
Bioorg Med Chem Lett
2009
18077069
Acute stress differentially affects corticotropin-releasing hormone mRNA expression in the central amygdala of the "depressed" flinders sensitive line and the control flinders resistant line rats.
Prog Neuropsychopharmacol Biol Psychiatry
2008
18973598
Chronic stress-induced alterations in amygdala responsiveness and behavior--modulation by trait anxiety and corticotropin-releasing factor systems.
Eur J Neurosci
2008
16904299
Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression.
Eur Neuropsychopharmacol
2007
16959374
Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze.
Peptides
2006
15845098
Down-regulation of amygdala preprotachykinin A mRNA but not 3H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia.
Eur J Neurosci
2005
12968131
Corticotropin-releasing hormone (CRH) mRNA expression in rat central amygdala in cannabinoid tolerance and withdrawal: evidence for an allostatic shift?
Neuropsychopharmacology
2004
12752772
Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain.
Eur J Neurosci
2003
11830177
Leptin suppression of hypothalamic NPY expression and feeding, but not amygdala NPY expression and experimental anxiety.
Pharmacol Biochem Behav
2002
11707630
Differential expression of NPY and its receptors in alcohol-preferring AA and alcohol-avoiding ANA rats.
Alcohol Clin Exp Res
2001
11244494
Differential expression of diacylglycerol kinase iota and L18A mRNAs in the brains of alcohol-preferring AA and alcohol-avoiding ANA rats.
Mol Psychiatry
2001
11377922
Neuropeptide Y Y(1) and Y(2) receptor mRNA expression in the prefrontal cortex of psychiatric subjects. Relationship of Y(2) subtype to suicidal behavior.
Neuropsychopharmacology
2001
11058155
Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression.
Proc Natl Acad Sci U S A
2000
11207429
Characterization of NPY mRNA-expressing cells in the human brain: co-localization with Y2 but not Y1 mRNA in the cerebral cortex, hippocampus, amygdala, and striatum.
J Chem Neuroanat
2000
10501568
Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder.
Neuroreport
1999
10327163
Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression.
Neurosci Lett
1999
9729278
Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment.
Brain Res Mol Brain Res
1998
9692720
On the relationship of neuropeptide Y Y1 receptor-immunoreactive neuronal structures to the neuropeptide Y-immunoreactive nerve terminal networks. A double immunolabelling analysis in the rat brain.
Neuroscience
1998
9692752
Regional distribution of neuropeptide Y Y2 receptor messenger RNA in the human post mortem brain.
Neuroscience
1998
9143015
NPY Y1 receptor like immunoreactivity exists in a subpopulation of beta-endorphin immunoreactive nerve cells in the arcuate nucleus: a double immunolabelling analysis in the rat.
Neurosci Lett
1997
9215705
Localization of neuropeptide Y Y1 mRNA in the human brain: abundant expression in cerebral cortex and striatum.
Eur J Neurosci
1997
1 - 49 of 49
Column Actions
Search
Recommended Authors
Nino Devidze
Gladstone Institute of Neurological Disease
Career Start Year
2003
Number of shared co-authors
2
Jan Mulder
Karolinska Institute
Career Start Year
1999
Number of shared co-authors
0
Andreas Reif
University Hospital Frankfurt am Main
Career Start Year
1998
Number of shared co-authors
5
John F Cryan
University College Cork
Career Start Year
1997
Number of shared co-authors
0
Shuye Pu
College Street, University of Toronto
Career Start Year
1996
Number of shared co-authors
0
Tatiana V Lipina
Institute of Neurosciences and Medicine
Career Start Year
1996
Number of shared co-authors
1
Mehrdad Shamloo
Stanford University School of Medicine
Career Start Year
1994
Number of shared co-authors
1
Sabine M H??lter
German Research Centre for Environmental Health
Career Start Year
1993
Number of shared co-authors
3
Roger Raymond
Campbell Family Mental Health Research Institute and Research Imaging Center
Career Start Year
1993
Number of shared co-authors
1
Jean-Michel Aubry
Geneva University Hospitals.
Career Start Year
1993
Number of shared co-authors
0
Paul D Shilling
University of California
Career Start Year
1992
Number of shared co-authors
0
Albert H C Wong
Campbell Family Mental Health Research Institute
Career Start Year
1990
Number of shared co-authors
1
Roger A Kroes
Falk Center for Molecular Therapeutics, Northwestern University
Career Start Year
1989
Number of shared co-authors
1
Herbert Herzog
Garvan Institute of Medical Research
Career Start Year
1987
Number of shared co-authors
0
Jacques Demotes-Mainard
The European Clinical Research Infrastructure Network (ECRIN)
Career Start Year
1986
Number of shared co-authors
1
Alessandra Valerio
University of Brescia
Career Start Year
1985
Number of shared co-authors
0
Vidar M Steen
University of Oslo, Oslo University Hospital
Career Start Year
1984
Number of shared co-authors
7
Martin Schalling
Karolinska Institutet.
Career Start Year
1982
Number of shared co-authors
2
Robert H Lipsky
George Mason University
Career Start Year
1980
Number of shared co-authors
2
Bryan L Roth
UNC Chapel Hill School of Medicine
Career Start Year
1980
Number of shared co-authors
1
Michelle E Ehrlich
Icahn School of Medicine at Mount Sinai
Career Start Year
1980
Number of shared co-authors
8
Fred Nyberg
University of Gothenburg
Career Start Year
1979
Number of shared co-authors
3
Jos?? N Nobrega
University of Toronto
Career Start Year
1978
Number of shared co-authors
1
Wade H Berrettini
University of Pennsylvania
Career Start Year
1977
Number of shared co-authors
2
Maria Del Zompo
University of Cagliari.
Career Start Year
1976
Number of shared co-authors
6
Roy Dayne Mayfield
Waggoner Center for Alcohol and Addiction Research, The University of Texas at Austin
Career Start Year
1976
Number of shared co-authors
0
Palmiero Monteleone
University of Salerno, University of Naples SUN.
Career Start Year
1973
Number of shared co-authors
2
Richard L Hauger
VA San Diego Healthcare System (VASDHS)
Career Start Year
1973
Number of shared co-authors
0
Robert Hitzemann
Portland Alcohol Research Center, Oregon Health and Science University
Career Start Year
1970
Number of shared co-authors
0
John I Nurnberger
Stark Neurosciences Research Institute, Indiana University School of Medicine
Career Start Year
1952
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Mario Lauria
University of Trento
Co-authored papers
9
Yasmin L Hurd
Co-authored papers
8
Corrado Priami
University of Pisa
Co-authored papers
6
Ian G Mills
Queen's University Belfast
Co-authored papers
1
Lawrence H Boise
Winship Cancer Institute, Emory University
Co-authored papers
1
Prerna Dua
Louisiana Tech University
Co-authored papers
1
Derrick Gibbings
University of Ottawa
Co-authored papers
1
Ekihiro Seki
Co-authored papers
1
Ezra E W Cohen
university of california san diego Health System
Co-authored papers
1
Nikolai Slavov
and Barnett Institute, Northeastern University
Co-authored papers
1
Christos Davatzikos
University of Pennsylvania
Co-authored papers
1
Juan Fueyo
The University of Texas M.D. Anderson Cancer Center
Co-authored papers
1
Nikolai V Gorbunov
Armed Forces Radiobiology Research Institute
Co-authored papers
1
J. Wade Harper
Harvard Medical School
Co-authored papers
1
Yu-Chuan Chang
Chang Gung Memorial Hospital-Linko, Chang Gung University
Co-authored papers
1
Yuriko Katsumata
University of Kentucky
Co-authored papers
1
Guanghua Xiao
The University of Texas Southwestern Medical Center
Co-authored papers
1
Jan Paul Medema
Oncode Institute
Co-authored papers
1
David M Sabatini
Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology
Co-authored papers
1
Arianna L Kim
Co-authored papers
1
Carlos L??pez-Ot??n
Instituto Universitario de Oncologia, Universidad de Oviedo
Co-authored papers
1
Ramil N Nurtdinov
The Barcelona Institute for Science and Technology
Co-authored papers
1
David Sulzer
New York State Psychiatric Institute, Research Foundation for Mental Hygiene
Co-authored papers
1
Ernst J Wolvetang
Australian Institute for Bioengineering and Nanotechnology, University of Queensland
Co-authored papers
1
Manish K Aghi
University of California san francisco
Co-authored papers
1
Hirotaka Watada
Co-authored papers
1
David A Bennett
Rush University Medical Center
Co-authored papers
1
Sara Cherry
University of Pennsylvania
Co-authored papers
1
Peter Robin Hiesinger
Co-authored papers
1
Hermann Pavenstädt
Co-authored papers
1
1 - 30